Schindler, Christoph
Birkenfeld, Andreas L.
Hanefeld, Markolf
Schatz, Ulrike
Köhler, Carsta
Grüneberg, Martin
Tschöpe, Diethelm
Blüher, Matthias
Hasslacher, Christoph
Bornstein, Stefan R.
Funding for this research was provided by:
Vifor Pharma AG
Article History
Received: 11 October 2017
First Online: 13 November 2017
Change Date: 6 December 2018
Change Type: Correction
Change Details: In the original publication, the text in Table 2 stated ‘Hypersensitivity to the active substance, to Ferinject, or to any of its excipients’.